Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan.

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Diabetes, Obesity & Metabolism Pub Date : 2024-08-29 DOI:10.1111/dom.15908
Yu-Hsin Yen, Fu-Shun Yen, Fu-Shun Ko, James Cheng-Chung Wei, Yuhan Huang, Teng-Shun Yu, Chii-Min Hwu, Chih-Cheng Hsu
{"title":"Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan.","authors":"Yu-Hsin Yen, Fu-Shun Yen, Fu-Shun Ko, James Cheng-Chung Wei, Yuhan Huang, Teng-Shun Yu, Chii-Min Hwu, Chih-Cheng Hsu","doi":"10.1111/dom.15908","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To assess the likelihood of dementia in individuals with type 2 diabetes (T2D), distinguishing between those with and without microvascular diseases.</p><p><strong>Methods: </strong>Leveraging the National Health Insurance Research Database in Taiwan, we identified individuals newly diagnosed with T2D from 1 January 2009 through 31 December 2014. Multivariable Cox proportional hazard models were used to compare the risk of outcomes.</p><p><strong>Results: </strong>Individuals with microvascular disease had a significantly higher risk of all-cause dementia (adjusted hazard ratio [95% confidence interval] 1.13 [1.09, 1.17]) compared with matched individuals without microvascular disease. In addition, individuals with diabetic kidney disease and diabetic neuropathy were associated with a significantly increased risk of Alzheimer's disease (1.16 [1.02, 1.32] and 1.14 [1.03, 1.27]), vascular dementia (1.21 [1.06, 1.38] and 1.14 [1.02, 1.28]) and other dementia (1.11 [1.04, 1.19] and 1.10 [1.04, 1.16]), respectively, compared with those without microvascular disease.</p><p><strong>Conclusions: </strong>This nationwide cohort study showed that patients with T2D and microvascular disease, particularly diabetic kidney disease and diabetic neuropathy, were associated with a significantly higher risk of Alzheimer's disease, vascular dementia, other dementia and all-cause dementia than those without microvascular disease.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":null,"pages":null},"PeriodicalIF":5.4000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.15908","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To assess the likelihood of dementia in individuals with type 2 diabetes (T2D), distinguishing between those with and without microvascular diseases.

Methods: Leveraging the National Health Insurance Research Database in Taiwan, we identified individuals newly diagnosed with T2D from 1 January 2009 through 31 December 2014. Multivariable Cox proportional hazard models were used to compare the risk of outcomes.

Results: Individuals with microvascular disease had a significantly higher risk of all-cause dementia (adjusted hazard ratio [95% confidence interval] 1.13 [1.09, 1.17]) compared with matched individuals without microvascular disease. In addition, individuals with diabetic kidney disease and diabetic neuropathy were associated with a significantly increased risk of Alzheimer's disease (1.16 [1.02, 1.32] and 1.14 [1.03, 1.27]), vascular dementia (1.21 [1.06, 1.38] and 1.14 [1.02, 1.28]) and other dementia (1.11 [1.04, 1.19] and 1.10 [1.04, 1.16]), respectively, compared with those without microvascular disease.

Conclusions: This nationwide cohort study showed that patients with T2D and microvascular disease, particularly diabetic kidney disease and diabetic neuropathy, were associated with a significantly higher risk of Alzheimer's disease, vascular dementia, other dementia and all-cause dementia than those without microvascular disease.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2 型糖尿病患者的微血管疾病及其与痴呆症的关系:台湾一项全国性队列研究。
目的:评估2型糖尿病(T2D)患者患痴呆症的可能性,区分有无微血管疾病:利用台湾国民健康保险研究数据库,我们对 2009 年 1 月 1 日至 2014 年 12 月 31 日期间新确诊的 T2D 患者进行了识别。采用多变量考克斯比例危险模型比较结果风险:结果:与无微血管疾病的匹配个体相比,患有微血管疾病的个体患全因痴呆症的风险明显更高(调整后危险比[95% 置信区间] 1.13 [1.09, 1.17])。此外,糖尿病肾病和糖尿病神经病变患者罹患阿尔茨海默病(1.16 [1.02, 1.32] 和 1.14 [1.03, 1.27])、血管性痴呆症(1.16 [1.02, 1.32]和 1.14 [1.03, 1.27])的风险也显著增加。27])、血管性痴呆(1.21 [1.06, 1.38] 和 1.14 [1.02, 1.28])和其他痴呆(1.11 [1.04, 1.19] 和 1.10 [1.04, 1.16])的风险:这项全国范围的队列研究表明,与无微血管疾病的患者相比,患有 T2D 和微血管疾病(尤其是糖尿病肾病和糖尿病神经病变)的患者罹患阿尔茨海默病、血管性痴呆、其他痴呆和全因痴呆的风险明显更高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
期刊最新文献
Continuous ketone monitoring: Exciting implications for clinical practice. Cofrogliptin once every 2 weeks as add-on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double-blind, non-inferiority trial. Changes in insulin utilization in China from 2020 to 2022. Visceral and subcutaneous adiposity and cardiovascular disease: Unravelling associations and prognostic value. A novel, centrally acting mammalian aminosterol, ENT-03, induces weight loss in obese and lean rodents.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1